Manufacturing and Production
NIHR funds COVID-19 antiviral trial
October 26, 2021 Manufacturing and Production
The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …
CHMP begins rolling review of COVID oral antiviral
October 26, 2021 Manufacturing and Production
The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …
Hospitals and pharmacies facing medicine shortages, says The London Economic
October 26, 2021 Manufacturing and Production
As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …
MHRA licenses uterine fibroid treatment for women in Great Britain
October 26, 2021 Manufacturing and Production
The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …
Hyloris announces approval of new drug for pain management
October 19, 2021 Manufacturing and Production
Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …
National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines
October 19, 2021 Manufacturing and Production
Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …
Lipocine and Antares Pharma enter agreement to commercialise TLANDO®
October 19, 2021 Manufacturing and Production
Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …
Global Heart Hub and Novartis form partnership to combat ASCVD
October 19, 2021 Manufacturing and Production
Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …
Symbiosis Pharma to manufacture Modus’ sepsis treatment
October 12, 2021 Manufacturing and Production
Modus Therapeutics, a company developing pharmaceutical therapies for diseases with high unmet medical need, has announced that Symbiosis Pharmaceutical Services …
Investment into mid-stage tech companies reaches new heights
October 12, 2021 Manufacturing and Production
31 companies have been accepted into Tech Nation’s Upscale growth programme for fast growing, mid-stage (Series A) scaling tech companies. …
SMC announces first long-acting injectable HIV treatment
October 12, 2021 Manufacturing and Production
The Scottish Medicines Consortium (SMC) has approved the first long-acting injectable regimen for people living with HIV in Scotland, manufactured …
AstraZeneca’s antibody cocktail cuts risk of severe COVID in half, study finds
October 12, 2021 Manufacturing and Production
AstraZeneca’s antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, has been successful …
UK government COVID response “one of UK’s worst ever public health failures”, inquiry finds
October 12, 2021 Manufacturing and Production, Medical Communications
A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …
Transgene and BioInvent to present oncolytic virus data at SITC 2021
October 5, 2021 Manufacturing and Production
Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …
AstraZeneca requests emergency authorisation for COVID-19 drug
October 5, 2021 Manufacturing and Production
AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …
Latest content
